| Secondary |
| Type 2 Diabetes Mellitus |
55.6% |
| Drug Use For Unknown Indication |
11.1% |
| Hypertension |
11.1% |
| Osteoarthritis |
11.1% |
| Schizoaffective Disorder |
11.1% |
|
| Angioedema |
42.9% |
| Hyperkalaemia |
14.3% |
| Musculoskeletal Disorder |
14.3% |
| Pulmonary Embolism |
14.3% |
| Syncope |
14.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.1% |
| Hypertension |
24.2% |
| Rheumatoid Arthritis |
6.4% |
| Cervicobrachial Syndrome |
4.7% |
| Diabetes Mellitus |
4.5% |
| Osteoporosis |
4.5% |
| Cardiac Failure |
3.3% |
| Osteoarthritis |
3.3% |
| Atrial Fibrillation |
2.6% |
| Type 2 Diabetes Mellitus |
2.4% |
| Cardiac Disorder |
2.1% |
| Malnutrition |
1.9% |
| Nephropathy |
1.9% |
| Carcinoid Tumour |
1.7% |
| Dyslipidaemia |
1.4% |
| Pneumonia |
1.4% |
| Angina Pectoris |
1.2% |
| Chronic Myeloid Leukaemia |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Chronic Lymphocytic Leukaemia |
0.9% |
|
| Myocardial Infarction |
7.4% |
| Wheezing |
7.4% |
| Blood Pressure Increased |
5.9% |
| Thrombotic Thrombocytopenic Purpura |
5.9% |
| Tuberculosis |
5.9% |
| Vomiting |
5.9% |
| Dyspnoea |
4.4% |
| Liver Transplant Rejection |
4.4% |
| Lung Neoplasm Malignant |
4.4% |
| Neutropenia |
4.4% |
| Oedema Peripheral |
4.4% |
| Pneumonia Bacterial |
4.4% |
| Sepsis |
4.4% |
| Staphylococcal Infection |
4.4% |
| Subdural Empyema |
4.4% |
| Subdural Haemorrhage |
4.4% |
| Tachycardia |
4.4% |
| Vision Blurred |
4.4% |
| Weight Decreased |
4.4% |
| Wound Infection |
4.4% |
|
| Interacting |
| Chronic Myeloid Leukaemia |
100.0% |
|
| Cough |
50.0% |
| Drug Interaction |
50.0% |
|
